Australia Patent: Memorial Sloan Kettering Cancer Center Files Application for 'Tumor mutational load and checkpoint immunotherapy'

Press/Media

Period12 Apr 2020

Media coverage

1

Media coverage

  • TitleAustralia Patent: Memorial Sloan Kettering Cancer Center Files Application for 'Tumor mutational load and checkpoint immunotherapy'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date12/04/20
    PersonsRobert Samstein